Sangamo Therapeutics Inc. (SGMO) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti

Sangamo BioSciences - SGMO emitenti grafik logotipi

GURU.Markets platformasidagi Sangamo Therapeutics (SGMO) kompaniyasining bozor qiymati grafigi, bunda ko'rsatkich -0.60 darajasida turibdi, tasdiqlangan aviaperuvuvchilar orqali biomateriallar logistikasining qat'iy nazoratiga asoslangan. Sangamo Therapeutics miya va jigarda DNKni maqsadli tuzatish uchun noyob "zinc finger" usuliga tayanadi. Fabri kasalligi davolash vositalarining muvaffaqiyatli sinovlari va sog'liqni saqlash gigantlaridan kelayotgan transhlar qiymatning oshishiga turtki bo'lmoqda.

Sangamo Therapeutics, Inc. (SGMO): Narxning foydaga nisbati 04.07.2022dan 09.05.2026gacha

Sangamo Therapeutics (SGMO) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning umumiy tahlili:Sangamo Therapeutics, Inc., SGMO
Sangamo BioSciences original mahsuloti

Sangamo Therapeutics (SGMO) DNA terapiyalarini ishlab chiqishga qat'iy bioetik standartlar va ESG tamoyillarini integratsiya qiladi, bu esa uning operatsion xarajatlar tuzilmasiga ta'sir ko'rsatadi. P/E koeffitsiyenti aksiyaning bozor qiymatini sof foydaga nisbatan aks ettirib, joriy daromad darajalaridagi investitsiyalarning qoplanish muddatini o'lchaydi. Yuqori qiymatlar shishirilgan o'sish kutsivlarini signalizatsiya qiladi, past qiymatlar esa aktivning qadrsizlanganini yoki mavjud xatarlarni ko'rsatadi. Kompaniyaning narx-foyda koeffitsiyentini tahlil qilish orqali investor joriy bozor baholovishining adolatli ekanligini aniqlaydi.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti TSHA|QURE - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori MGTX|Biznesning o‘zini qoplash muddati regenxbio.com|P/E multiplikatori SLDB (Solid Biosciences Inc)|OCGN: Narx-foyda multiplikatori|PACB - Narxning foydaga nisbati|Benitec (BNTC) - Narx-foyda koeffitsiyenti|DSGN: P/E multiplikatori|RCKT: Bozor narxining sof foydaga nisbati|FDMT (4D Molecular Therapeutics, Inc.) - P/E multiplikatori|lexeotx.com (LXEO) - Biznesning o‘zini qoplash muddati|P/E multiplikatori KRRO|Narx-foyda koeffitsiyenti Editas Medicine, Inc. EDIT|Narxning foydaga nisbati silence-therapeutics.com SLN|PRQR: Narx-foyda multiplikatori|CDXS - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati